IntroductIon MicroRNAs (miRNAs) are small RNAs that play an important role in the regulation of gene expression. miRNA dysregulation has been associated with phenotypic changes, including cardiovascular diseases (CVDs).
IntroductIon MicroRNAs (miRNAs) are small, endogenous, single-stranded, noncoding eukaryotic RNAs of 20 to 24 nucleotides in length. They play an important role in the process of gene expression. They mediate post-transcriptional regulation by complementary pairing with encoding genes' mRNA, which usually leads to translational repression of target mRNA, its degradation, and gene silencing. 1 More than 1500 different human miRNA sequences have already been found, and it is estimated that the expression of about 30% to 60% human genes can be regulated via miRNA interaction. 2,3
The key location for miRNA activity is the so called "seed region", consisting of 2 to 7 nucleotides within the 5' strand, which seems to be a crucial factor for determining miRNA functionality. 1 This is confirmed by cases where single--point mutations within the miRNA seed region (or the corresponding target site) are able to significantly reduce the effectiveness of miRNA interaction or entirely deprive it of its regulatory capability, thereby altering the expression of the regulated gene. 4 The mature miRNA strand regulates gene expression by complementary binding with mRNA, which in the case of extensive complementarity orIGInAL ArtIcLE -StudEnt AWArd WInnEr 2013* In-silico identification of cardiovascular disease-related SNPs affecting predicted microRNA target sites potential therapeutic agents for the treatment of CVDs has been proposed. 6 Although genome-wide association studies (GWAS) indicate numerous connections between single nucleotide polymorphisms (SNPs) and phenotypes, leading to the conclusion that these genetic variants are able to significantly affect the course of CVD, 7 they do not provide direct information on the possible mechanisms by which these modulations occur. Given the association of multiple polymorphisms with CVDs, the presence of functional SNPs in noncoding intron sequences, 8 and the effect of miRNAs on gene transcription, we hypothesize that SNPs within miRNA binding site, by destroying the existing or creating novel target sites or by changing miRNA binding strength, may change its effects on gene expression, which results in the onset or change in the course of CVD. In this paper, based on an in-silico analysis, we would like to determine whether there exist miRNAs associated with CVDs by the coexistence of SNPs interfering with their function, and, if so, to indicate the specific ones.
In silico is, apart from in vivo or in vitro, one of the experimental techniques. It represents a modern approach to research, based on the use of computing power to perform mathematical analyses of a large amount of data and the creation of complex databases.
MAtErIALS And MEthodS
Based on the in-silico method, 3 factors -SNPs, CVDs, and miRNAswere subjected to analysis. Databases available in public domains, based on the previous experiments and containing a set of SNPs associated with the phenotype of interest (CVD) and SNPs located in known miRNA binding sites, were obtained. By transforming the structure of both database types and by merging the records assigned by the same SNP, we were able to indicate the miRNA target site, the SNPs of which may be associated with CVDs. These results were further analyzed with the use of additional computational tools (FIGurE 1) .
To obtain a list of SNPs associated with CVDs, an "Open Access GWAS Database", 9 built on the basis of 118 GWAS articles, was used. Only the SNPs related to CVDs, such as MI, coronary artery disease (CAD), subclinical atherosclerosis (SA), and arterial hypertension (HT), were extracted.
Because of the low number of entries associated with MI, we decided to extend the list by additional entries, obtained from the available medical literature. Via a PubMed search, 225 additional SNPs affecting the risk of MI were identified and included in the downloaded database.
By downloading databases available online, we obtained a list of SNPs with a computationally demonstrated effect on known miRNA binding sites. Due to the computational nature, and hence the need for experimental verification, 2 different databases were downloaded, created on the basis leads to the enzymatic degradation of the target. However, more often other interactions occur due to a lower grade of affinity, namely, translational repression or its initiation inhibition, mRNA destabilization, poly(A) tail shortening or combination of the above. The opposite phenomenon is positive regulation mediated by transcriptional or translational activation. A list of circulating miRNAs was gathered based on miRandola database resources. 14 The database was searched for each miRNA obtained in this study, and each positive result was included in the table.
To compare the changes in mRNA expression caused by the difference in an SNP allele, an online application -Genevar -was used. 15 The Expression Quantitative Trait Locus (eQTL) analysis of SNP--gene relations was based on the HapMap3 study. 16 rESuLtS On the basis of the present in-silico analysis, the computationally identified variants that may affect the regulation of gene expression, and thus the existence of disease through changes within miRNA binding sites, are herein specified.
From the "open-access GWAS database" containing 56,411 significant SNP-phenotype associations, after filtering out entries associated with CVDs (MI, CAD, SA, HT), 1331 results (2.35%) were merged with 225 results for MI derived from PubMed. This gave a total of 1556, of which 241 (15.49%) were related to MI, 1059 (68.06%) to CAD, 97 (6.23%) to SA, and 13 (0.84%) to HT. of different algorithms, allowing both to expand the range of data subjected to the study and indicate hypothetically more likely interactions. The databases used were PolymiRTS Database 2.0 10 and mirSNPscore. 11 Due to the different origins and methods of data storage, both underwent modification. The databases were exported to.xls filetype with MS Excel 2010 and numerous scripts and macros were used, allowing to merge the cells and rows, automatic search, content comparison, and conditional formatting.
As the final step allowing to identify the association between miRNAs and the phenotype included in the databases, we searched the content of integrated databases for GWAS entries using an SNP ID as the common variable for both databases. As a result, a list of miRNA-SNP allelephenotype triplets was obtained (tAbLE 1) .
miRNAs identified in the present study were analyzed for the changes in expression between the various tissues. This was possible through the use of miRNA body map database. 12 Only the records for which the change of expression in the tissues of the cardiovascular system was at least 1.5-fold were gathered. A similar search was performed for miRNAs within the same family.
By using the mimiRNA tool, 13 it was possible to analyze the collected miRNA-mRNA pairs Another analysis referred to the comparison of the modulated gene expression level depending on the SNP within it. It was possible based on the results of the previous cis-eQTL studies (expression Quantitative Trait Loci) that showed a statistically significant relationship between the gene transcript abundance and SNP allele present in the immediate vicinity of the gene. Using the Genevar expression dataset to analyze 13 SNPs, 4 were identified (rs3803, rs3 217 989, rs3 217 992, rs2 813 563), for which the difference in gene expression reached statistical significance in one of the studied populations (FIGurE 2) .
Three of the tested miRNAs (miR-181a-2*, miR-628-5p, miR-378*) featured a variable After querying PolymiRTS and mirSNPscore databases with the combined results obtained from the literature and Johnson's database, a list of 47 entries constituting unique miRNA-SNP allele-phenotype linkages, was obtained (tAbLES 1 and 2) . Eleven of them were computationally predicted by both databases. The results include 8 different SNPs, which are linked with all of 4 studied phenotypes (MI, CAD, SA, HT), occur within 12 genes, and may affect the binding of 45 different miRNAs. It is predicted that as a result of this interaction, miRNA would lose its function in 25 cases, gain the ability to interact with the modified locus in 17, and change binding strength in 3. differences in miRNA coexpression, tissue--dependent miRNA expression, and significant eQTL effect for the indicated SNP-mRNA pairs, substantiated on the basis of earlier experimental studies, makes this hypothesis even more likely. It has to be acknowledged that the accuracy of the above statement is based on the assumption that the databases used in the study, built on the basis of computational algorithms, are characterized by high prediction accuracy, indicate interactions on the SNP-miRNA line actually existing in vivo, and correctly identify miRNAs' targets. For obvious reasons, the applied mechanisms 2,11 are based on a simplified model of the miRNA function, focusing the analysis on the seed region and minimizing the effect of interactions affecting the rest of the strand.
1, 17 The heterogeneity of both databases used in the analysis may come from the use of different algorithms. On the other hand, overlapping of the results seems to justify the use of those sources as well as allow for a more accurate prediction.
The possibility of using computational methods as an approximation only is a significant limitation. For this reason, further investigation involving experimental laboratory methods is required to verify the presented interdependencies. The verification procedure may include examination of coexpression for the remaining miRNA-mRNA transcript pairs, SNPs in coexistence with gene expression changes, and miRNA expression profiles impaired in patients with the phenotype of interest. The necessity to expression levels in the tissues of the cardiovascular system, and 7 other showed a similar relationship within their family. This may speak for their participation in the transcriptional regulation within the heart and blood vessels (FIGurE 3) .
To extend the results, another test was conducted in which miRNA-mRNA transcript pairs were analyzed for coexpression, assuming that the simultaneous expression of miRNA and its target increased the chances that the tested pairs were functional. Using the mimiRNA database, coexpression data for 14 of the 47 predictions have been found, of which 2 (CDKN2B-miR-655, NRSN1-miR-520h) reached statistical significance combined with a high correlation coefficient (FIGurE 4) .
Given the fact that some miRNAs, while being secreted into and transported through the bloodstream, do not have to act locally, their level of expression and coexpression with the target mRNA does not necessarily need to correlate with their functionality. Among our results, there were 15 circulating miRNAs; however, one of them, still shows a significant coexpression level (miR-655).
dIScuSSIon Our results support the hypothesis that interactions on the SNP-miRNA line may imply phenotypic changes. This suggestion can be put forward based on the incidence of the common points found for both types of independently curated databases, gathering the SNP-phenotype and miRNA-SNP dependences. The existence of significant 
FIGurE 2
Single nucleotide polymorphisms with significant cis-regulatory effects (P emp <0.05); each graph describes transcript expression levels depending on the genotype; data derived from Stranger et al. 16 were analyzed with the Genevar software; graphs generated with the Genevar software Abbreviations: MKKMaasai in Kinyawa, Kenya (HapMap3 population), LWKLuhya in Webuye, Kenya after (HapMap3 population), P empempirical P-value 10,000 permutations indicated in this paper lays within such a region. The locus identified in this case is 9p21.3, correlated with numerous CVDs. Changes in gene expression were associated with CAD 19 and confirmation for these experiments are provided by GWAS, in which CDKN2B SNPs have been associated with atherosclerosis 20 and CAD. 21 Of note, the ANRIL gene, antisense to CDKN2B, is situated in the same location. Although all of its transcripts are noncoding RNA, it has been assigned a number of key functions such as involvement in epigenetic changes 22 and modulation of the expression of genes responsible for the process of atherogenesis, 23 which is further confirmed by its altered expression in haplotypes associated with atherosclerosis 20 and CAD. 24 The GWAS conclusions for ANRIL are consistent with the results provided for CDKN2B, suggesting the involvement of ANRIL SNPs in the pathogenesis of CAD 7 and atherosclerosis. 25 The involvement of noncoding RNA in many complex processes suggests the need to search for causative factors not only among the coding genes but also within other loci.
Particularly noteworthy is the characteristic of the rs3217992 polymorphism, which hypothetically affects miRNA-205 binding, specified for the CDKN2B gene.
rs3217992 is associated with the occurrence of MI, and its presence has a negative effect (demonstrates cis-acting effects) on the expression of CDKN2B and ANRIL, 26 which was confirmed by the tools used in the present analysis.
15,16
confirm the results of an in-silico analysis using experimental techniques does not undermine the validity of performing such an analysis, which is considered to be extremely useful when handling a large number of potential interactions.
A notable result of the analysis is a significant reduction in the range of possible interactions. Limiting the number of considered interactions to the most probable and their stratification on the basis of prediction probability allows to direct further research for the particular cases and to make them more cost-and time--effective. The in-silico analysis can be regarded as a preliminary, useful stage of genome research, the numerous components of which can interact in various combinations.
Unfortunately, one cannot exclude the possibility that a relatively small number of identified interactions may result from an accidental database overlap. On the other hand, this number may be underestimated if we allow for the fact that not all of the possible mechanisms of interaction between SNPs and miRNA were considered.
18 SNPs may also exist within the miRNA seed itself, within protein complexes determining the miRNA function or mediating its maturation, its intermediate forms, and, finally, within the transcription factors regulating miRNA expression.
At this stage, indirect confirmation of the obtained results can be inferred from the available studies.
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system. Moreover, not in all cases a functional miRNA must demonstrate mutual expression with its target mRNA within the examined tissue. The existence of circulating miRNAs subjected to exocytosis and transported in serum in the form of exosomes or complexes with high-density lipoprotein and Ago2, showing an intracellular activity, has been proved. The discovery of novel candidates brings the opportunity for developing new diagnostic methods based on serum miR-NA expression profile 31,32 and use of appropriate miRNA analogues or inhibitors as therapeutic agents in the future.
6,33
miR-205, for which the coexpression with the CDKN2B gene has been demonstrated, was found to be overexpressed in ischemic striated muscle of the rat 27 and correlated with metabolism of the failing heart.
28
Still not much is known on the effects of miR-NA on the cardiovascular system, and this is the main issue addressed in the present publication. Based on the previous studies, it can be concluded that associations with CVDs have been shown for some of herein identified miRNAs (as is the case for miR-483-5p showing the relationship with angiogenesis 29 or miR-224 showing altered expression profile in myocardial hypertrophy). 30 Moreover, miRNA function is often associated with the effect on the course of neoplasia. Although similar association studies are also conducted for miRNAs relation to phenotype and pathophysiology of the cardiovascular system, they are far less numerous. Given the positive results of studies linking tumor development with miRNA expression, a strong effect of genetic factors on cardiovascular risk, and the possibility that miRNA affects the function of genes associated with CVDs as discussed in this study, we conclude that the studies on miRNAs are extensive, untapped niche, which allows to show their relationship to the pathology of the cardiovascular 
